New Study Shows How mRNA Vaccines Could Transform Cancer Treatment

Researchers found that melanoma patients who received a personalized mRNA vaccine plus immunotherapy had better five-year cancer-free and survival outcomes than those on immunotherapy alone.

The vaccine is tailored from each patient’s tumor mutations to train the immune system to recognize and attack cancer cells.

Scientists are now testing whether the approach could work for other cancers, including lung and kidney cancer.

The results suggest personalized mRNA vaccines could become a new add-on treatment model for improving long-term cancer survival.